Head-to-head · WeighScore
boostAGErx vs Teleios Health
The verdict
boostAGErx takes it — 66.1/100 to 60.2/100.
boostAGErx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. boostAGErx is a longevity-focused telehealth service selling compounded GLP-1 weight management alongside peptide therapy.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | boostAGErx | Teleios Health |
|---|---|---|
| WeighScore | 66.1/100 | 60.2/100 |
| Grade | C | C |
| Scorecard rank | #201 | #327 |
| Semaglutide | $95/mo (billed every 28 days, compounded) | $99/mo (starting dose, compounded) |
| Tirzepatide | $145/mo (billed every 28 days, compounded) | $139/mo (starting dose, compounded) |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #201 · C
Strengths
- Compounded GLP-1 starting around $95/mo (12-month plan paid upfront)
- Free shipping and clinical evaluation included
- Membership fee refunded in full if you're not approved
- Also offers peptide therapy such as sermorelin
- 100% online with licensed providers — no clinic visit
Where it loses points
- Billing runs on a 28-day cycle rather than a calendar month — thirteen charges a year, so the $145 tirzepatide rate is $1,885 a year, an effective $157/mo
- The terms call the charge a 'membership fee' while the marketing carousel says 'No Membership Fees Ever'
- Prices are rendered entirely in JavaScript; the page's HTML body is empty, so nothing is readable without running the bundle
- Shipped compounded medication is non-refundable
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
Graded #327 · C
Strengths
- Compounded semaglutide from $99/mo — among the lowest floor prices in cash-pay telehealth
- Compounded tirzepatide from a competitive $139/mo floor
- Markets physician (MD/DO) prescribing rather than an NP-only model
- Clean meta-tag and SEO implementation
Where it loses points
- Single-page app: state availability, pharmacy partner, dose pricing, lab requirements, and refund policy aren't visible and couldn't be verified
- No named medical director, physician, or corporate entity disclosed
- Year founded unknown — a newer floor-price entrant warranting extra scrutiny
- No LegitScript, NABP, or SOC 2 trust signal found
- Heavy paid-acquisition ad-tech stack — pair with diligence on the clinical layer
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.